Family Food Allergy Foundation Memorializes Elijah-Alavi

Elijah-Alavi

The parents of three-year-old Elijah-Alavi were devasted by the loss of their son. While at preschool, Elijah, who had food allergies including dairy, was mistakenly given a grilled cheese sandwich. He suffered a fatal attack of anaphylaxis. From that tragedy Elijah’s parents embarked on a path of advocacy and education, so that other parents wouldn’t have to experience the same heartbreak. They founded the Elijah-Alavi Foundation, which includes “Elijah's Echo,” an initiative raising awareness of food allergies and anaphylaxis.    Read the article here.

The Do’s and Don’ts of Preventing Peanut Allergies in Babies

The Do’s and Don’ts of Preventing Peanut Allergies in Babies

After being told for years to avoid giving allergens such as peanuts and shellfish to children, the National Institute of Allergy and Infectious Diseases (NIAID) is now recommending that parents introduce children to peanuts in the first four to six months of life, based on their child’s risk level. Below are some excellent guidelines to help determine what that risk level might be and how to include peanuts in a baby’s diet. Always check with your pediatrician first before feeding your child any potential allergens.

Peanuts and Opened Shell

Scientists say early and consistent feeding of peanuts can help prevent peanut allergies in children. A food allergy expert explains what parents should know.

By Rebecca Priest
January 31st, 2017

Food allergies have grown in prevalence and severity, and until recently pediatricians have told parents to keep their babies away from peanuts, shellfish and other common allergenic foods.

New recommendations from food allergy experts, however, suggest parents should do exactly the opposite.

This month, the National Institute of Allergy and Infectious Diseases (NIAID) outlined guidelines for introducing children to peanuts in the first four to six months of life based on each child’s risk level.

Continue Reading

E-Greetings from the Allergy Advocacy Association

E-Greetings from the Allergy Advocacy Association

February, 2017

Valentine greetings! We hope this finds you enjoying winter activities or getting the heck out of town to warmer weather. Hope (and love) is in the air with several new initiatives in the works to help those with serious food allergies. Pharmaceutical companies are lowering the cost of epi-pens and developing new treatments such as peanut patches. This month we are also offering very practical guidelines to introduce small amounts of peanut foods to infants who are at risk of developing food allergies.

As the days grow longer, hope springs eternal.

The Viaskin Peanut Patch: Will It Help Prevent Anaphylaxis?

Local allergist Dr. Shahzad Mustafa has been closely monitoring clinical trials for a new peanut patch that would help decrease the risk of an allergic reaction after accidental ingestion. Worn on the back or the inside of the upper arm, there were very few side effects in a recent study except for mild skin irritations. After 1-2 years of using the patch, close to 50% of the 74 participants saw a 50% improvement in peanut tolerance. DBV Technologies hopes to have the product approved by the Food and Drug Administration and marketed by 2018.

The Viaskin Peanut Patch: Will It Help Prevent Anaphylaxis?

Viaskin Peanut Patch

By Janet Goldman
February 11th, 2017

DBV Technologies has been developing the Viaskin Peanut Patch, a new method for preventing anaphylaxis. If used appropriately, the patch can increase tolerance to peanuts. The patch helps peanut allergic individuals who accidentally ingest or are accidentally exposed to peanut protein. Through immunotherapy, the patch can help prevent symptoms from an accidental exposure. However, even with a patch, users should still always carry epinephrine and strictly avoid peanuts.

Continue Reading

Auvi-Q Offers Possible Alternative to Epi-Pen(TM)

Auvi-Q Offers Possible Alternative to Epi-Pen

A “free” epi-pen? Could this ever be possible? Kaleo’s Auvi-Q will re-enter the U.S. market on February 14th of this year and the company is determined to be the lowest cost alternative. Anyone with commercial insurance would not have to pay a dime, and Kaleo will even cover the cost of co-pays. Only those who make more than $100,000 a year and have no insurance or government coverage will be charged a maximum of $360. However, most insurance companies have not yet commented on whether they will cover the Auvi-Q. It is certainly nice to have alternatives and not rely on just one company to offer affordable pricing for lifesaving epi-pens.

Various Epinepherine Injectors

By Kristen Stewart
February 6th, 2017

Anyone with severe allergies knows the importance of having an epinephrine auto-injector (EAI) at the ready. However, with the Epi-PenTM jumping more than $500 in price in the last eight years and until recently no other companies having an epinephrine auto-injector device available, not everyone can afford this potentially life-saving medication. That may be about to change as Kaleo’s Auvi-Q re-enters the U.S. market on February 14th.

Continue Reading

The information provided on this site is in no way intended to be a substitute for medical advice,
diagnosis, or treatment with a licensed physician.
The Allergy Advocacy Association is a 501(c)(3) non-profit, tax-exempt organization.
Copyright 2020 © Allergy Advocacy Association, Inc. All rights reserved.  Terms & Conditions